南美旅行疫苗市场预测至 2028 年 - COVID-19 影响和按产品（甲型肝炎、乙型肝炎、脑膜炎球菌疫苗等）和应用（国内旅行和出境旅行）进行区域分析
No. of Pages: 104 | Report Code: BMIRE00025527 | Category: Life Sciences
No. of Pages: 104 | Report Code: BMIRE00025527 | Category: Life Sciences
SAM 旅行疫苗市场已细分进入巴西、阿根廷和 SAM 的其他地区。在预测期内，由于区域疾病患病率上升、技术创新迅速、疫苗开发以及老年人口增加，预计该地区将继续占据主导地位。巴西是该地区主要的疫苗生产国。该国可自给自足 54% 的疫苗接种需求，包括 DTP、成人和婴儿 DT、TT、HepB 和 DTP 联合疫苗（DTP-HB 和 DTP-HB-Hib）、季节性流感疫苗、YF 疫苗和脑膜炎 AþC.巴西是全球黄热病疫苗主要生产国之一，市场价格最低。与巴西类似，阿根廷也是该地区最大的国家。阿根廷是中高收入经济体，工业部门多元化。 2021年，阿根廷国内生产总值为1233.69亿美元。过去五年，阿根廷国内生产总值复合增长率为6.8%。推动市场增长的主要国家包括智利、哥伦比亚、秘鲁、古巴、委内瑞拉和玻利维亚。这些国家为市场的增长提供了巨大的增长机会。该地区对疫苗研究的日益重视、疫苗开发技术的不断进步以及政府在药品研发方面的支出增加等因素预计将推动旅行疫苗市场的发展。
;
借助新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动 SAM 旅行疫苗市场的发展。预计 SAM 旅行疫苗市场在预测期内将以良好的复合年增长率增长。
SAM 旅行疫苗市场分为产品、应用和国家。 SAM 旅行疫苗市场根据产品分为甲型肝炎、乙型肝炎、脑膜炎球菌疫苗等。 2021年，其他细分市场占据最大市场份额。 SAM 旅行疫苗市场根据应用分为国内旅行和出境旅行。 2021年，出境游细分市场占据最大份额。根据国家/地区，SAM 旅行疫苗市场分为巴西、阿根廷和 SAM 的其他地区。
雅培；葛兰素史克公司；默克公司有限公司；诺华公司；辉瑞公司；和赛诺菲是该地区旅行疫苗市场的领先公司之一。
Strategic insights for South America Travel Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 143.20 Million |
| Market Size by 2028 | US$ 243.85 Million |
| Global CAGR (2021 - 2028) | 7.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South America Travel Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South America Travel Vaccines Market is valued at US$ 143.20 Million in 2021, it is projected to reach US$ 243.85 Million by 2028.
As per our report South America Travel Vaccines Market, the market size is valued at US$ 143.20 Million in 2021, projecting it to reach US$ 243.85 Million by 2028. This translates to a CAGR of approximately 7.6% during the forecast period.
The South America Travel Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Travel Vaccines Market report:
The South America Travel Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Travel Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Travel Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South America Travel Vaccines Market
